| Document |
Document Title |
|
WO/2012/154854 |
The present disclosure relates to the use of pantothenate compounds as a non-genetic switch for the production of heterologous acetyl-CoA derived (HACD) compounds in microbial host cells. The invention provides genetically modified micro...
|
|
WO/2012/152270 |
The invention relates to a microorganism, of the order of lactic acid bacteria or analog, fragment, derivative, mutant or combination thereof. Said microorganism, or analog, fragment, derivative, mutants or combination thereof can be co-...
|
|
WO/2012/154651 |
The present invention relates to, inter alia, a method for repressing transcription and/or gene expression from RpoN binding sites (or promoters) or cryptic promoters upstream of RpoN binding sites. The method comprises providing an agen...
|
|
WO/2012/151647 |
The present invention relates to the production of a genetically engineered strain of Bacillus subtilis that exhibits an expression system controlled by substitution of the promoter region. The present invention also relates to the metho...
|
|
WO/2012/154072 |
For the first time, an O-specific polysaccharide antigen that is a Shigella sonnei phase I exopolysaccharide has been produced and characterized, said exopolysaccharide being an authentic natural compound in the form of a bacterial capsu...
|
|
WO/2012/153089 |
A method for releasing the content of the periplasmic space of bacterial celis is provided, which comprises incubating the bacterial cells in a solution containing styrene maleic acid copolymer (SMA). Also provided is a method of prepari...
|
|
WO/2012/154651 |
The present invention relates to, inter alia, a method for repressing transcription and/or gene expression from RpoN binding sites (or promoters) or cryptic promoters upstream of RpoN binding sites. The method comprises providing an agen...
|
|
WO/2012/153620 |
The present invention specifies a novel protein carrier for a peptide for therapeutic use and provides a series of techniques using the aforesaid carrier. Provided is a drug comprising a fused protein wherein apolipoprotein AI or a modif...
|
|
WO/2012/152680 |
The invention relates to a Lactobacillus fermentum strain with probiotic properties and enhanced activity against enteropathogens. The strain is Lactobacillus fermentum CECT 7472, which may be used as an ingredient in edible products, wh...
|
|
WO/2012/153247 |
The invention relates to the use of at least one chelating agent, including an iron chelating agent, in order to stimulate the growth of magnetotactic bacteria.
|
|
WO/2012/150968 |
One of the most important technical barriers for algal biofuel is the substantial harvesting and extracting cost, The present invention includes a system and method for the peiletization of single cell microalgae through co-cultivation w...
|
|
WO/2012/150696 |
The present invention relates to: a modified lipase which has a higher carbamatation activity than that of a wild type thereof represented by SEQ ID NO: 1 and which is produced by the substitution of a glutamine residue located at positi...
|
|
WO/2012/150861 |
The present invention relates to a method for screening for a bacterium exhibiting enhanced survival properties in the gastro-intestinal tract. The present invention further relates to a method for screening for culture conditions that p...
|
|
WO/2012/150976 |
The present invention relates to compositions and methods for stable transformation of green microalgae and for production of transgenic green microalgae and/or cyanobacteria that produce extremophile enzymes as co-products during the gr...
|
|
WO/2012/150976 |
The present invention relates to compositions and methods for stable transformation of green microalgae and for production of transgenic green microalgae and/or cyanobacteria that produce extremophile enzymes as co-products during the gr...
|
|
WO/2012/151382 |
A system for inoculating soil with microalgae is provided. The system is portable and can be used with many different water sources to culture microalgae and form an inoculate that is added to irrigation water used for watering crops. Th...
|
|
WO/2012/151382 |
A system for inoculating soil with microalgae is provided. The system is portable and can be used with many different water sources to culture microalgae and form an inoculate that is added to irrigation water used for watering crops. Th...
|
|
WO/2012/149622 |
The present invention describes a skin test characterised in that it comprises protein antigens secreted by Corynebacterium pseudotuberculosis for diagnosing subclinical caseous lymphadenitis in goats and sheep. This test allows goats an...
|
|
WO/2012/150683 |
[Problem] To produce a glycosylceramide composition which is suitable for a functional food, a medicinal product and the like and has stable quality, and from which contaminants such as sterol glycosides are removed, specifically to prod...
|
|
WO/2012/151481 |
The present invention relates to anti-MASP-2 inhibitory antibodies and compositions comprising such antibodies for use in inhibiting the adverse effects of MASP-2 dependent complement activation. In one aspect, the invention provides an ...
|
|
WO/2012/149883 |
The invention discloses transgenic plants having increased growth rate and increased yield and methods for making the same. In one embodiment, the method comprises: transforming a plant or plant cell with a nucleic acid molecule comprisi...
|
|
WO/2012/149162 |
Disclosed are organisms genetically engineered to make useful products when grown on ethanol as a carbon source. The organisms are genetically engineered to produce various useful products such as polyhydroxyalkanoates, diols, diacids, h...
|
|
WO/2012/149469 |
The invention features compositions and methods for the increased production of mevalonate, isoprene, isoprenoid precursor molecules, and/or isoprenoids in microorganisms via the heterologous expression of the mvaE and mvaS genes from th...
|
|
WO/2012/149484 |
Disclosed herein are methods and compositions for the cryopreservation of stem cells, such as stem-cell derived retinal pigment epithelial cells, that have been seeded onto and cultured on a substrate, such as a polymeric substrate. Such...
|
|
WO/2012/145835 |
There is provided a process for growing a phototrophic biomass, such as microalgae or photosynthetic bacteria, in a bioreactor. The process includes the provision of at least a fraction of a carbon dioxide-rich product material to the bi...
|
|
WO/2012/147903 |
Provided is a mutant strain of yeast that has been imparted with lactic acid producing capability by transfection with a lactate dehydrogenase gene. The mutant strain of lactic acid producing yeast is characterized in that the lactic aci...
|
|
WO/2012/145806 |
In the present invention, two important agroindustrial wastes ("manipueira", i.e. liquid extracted from cassava roots, and malt bagasse) are used for ethyl hexanoate production by the Neurospora sitophila FGSC 1135 strain. The present in...
|
|
WO/2012/147989 |
The present invention provides a method for producing an L-amino acid belonging to the glutamate family, using a coryneform bacterium which has been modified so that expression of one or more gene(s) of the NCgl_2067-NCgl_2065 operon in ...
|
|
WO/2012/149058 |
Provided herein are methods and systems for interfering with viability of bacteria and related compounds and compositions.
|
|
WO/2012/146953 |
The invention relates to nisin-resistant lactobacilli and their use for preparing food products with reduced post-acidification.
|
|
WO/2012/145949 |
A Protaminobacter alboflavus CGMCC No.4670 for displacing oil, a composite oil-displacement agent comprising such microorganism and preparing methods thereof are provided, wherein the composition and weight percent of the composite oil-d...
|
|
WO/2012/146338 |
The present invention relates to a method for the lysis of cells, especially bacterial cells and the isolation of nucleic acids. The sample is treated with lysis solution that comprises at least one liquid that is not miscible with water...
|
|
WO/2012/147928 |
Provided are: an agent for preventing bacterial wilt disease, which can prevent the onset of bacterial wilt disease caused by various different bacterial wilt disease strains, i.e., the onset of bacterial wilt disease in various differen...
|
|
WO/2012/146937 |
The present invention relates to a newly-identified lipase enzyme isolated from a member of the Ustilaginaceae family of the Basidomycetes, and to polypeptide variants thereof, that exhibit increased trans-selectivity, and/or increased p...
|
|
WO/2012/147048 |
The present disclosure relates to methods of decreasing lactate production in cell culture using divalent transition metal salts. The effect on lactate production of copper and zinc at concentrations ranging from 0.2 to 0.4 mM is particu...
|
|
WO/2012/149162 |
Disclosed are organisms genetically engineered to make useful products when grown on ethanol as a carbon source. The organisms are genetically engineered to produce various useful products such as polyhydroxyalkanoates, diols, diacids, h...
|
|
WO/2012/147905 |
Provided is a promoter activity enhancer. A promoter activity enhancer comprising a compound represented by formula (I).
|
|
WO/2012/147553 |
The present invention can efficiently reduce nitrates, nitrites, etc. generated in nature such as swamps, ponds, lakes, rivers, seas, and marshy places or in aqueous environments of artificial devices such as ornamental or aquaculture wa...
|
|
WO/2012/147713 |
The present invention relates to an antibody which has a therapeutic effect on tumors. Namely, the present invention relates to an antibody which binds to B7-H3 and exhibits antitumor activity. The objective of the present invention is t...
|
|
WO/2012/149491 |
The invention features compositions and methods for the increased production of mevalonate, isoprene, isoprenoid precursor molecules, and/or isoprenoids in microorganisms by engineering a microorganism for increased carbon flux towards m...
|
|
WO/2012/149439 |
IL4/IL13-binding proteins comprise binding domains, which inhibit IL4/IL13 binding to IL4Ralpaha and common gamma chain complexes (Type 1 ) and inhibit IL4 binding to IL4Ralpha and IL13Ralpha1 complexes (Type 2), and IL13 binding to IL13...
|
|
WO/2012/145848 |
This invention relates to a process for the production of microalgal biomass for species of the genus Haematococcus. Using this process the rate of biomass production and the biomass astaxanthin content are increased. An embodiment of th...
|
|
WO/2012/149058 |
Provided herein are methods and systems for interfering with viability of bacteria and related compounds and compositions.
|
|
WO/2012/148995 |
A living hydrated mycelium composite containing at least one of a combination of mycelium and fibers, mycelium and particles, and mycelium, particles and fibers is processed with a nutrient material to promote mycelia tissue growth; ther...
|
|
WO/2012/146935 |
Disclosed are modified lipase enzymes, as well as polynucleotides and recombinant expression vectors encoding the lipase variant polypeptides, as well as methods for producing such lipase variants in selected bacterial and fungal host ce...
|
|
WO/2012/149404 |
This document provides methods and materials involved in making and using liquid vaccine preparations for oral administration. For example, methods and materials for making and using liquid vaccine preparations for oral administration th...
|
|
WO/2012/145803 |
This invention relates to a polymer product comprising the components consisting of a polymer in form of granules; a multidimensional structure containing amphiphilic molecules, such as lipids, surfactants or polymers, wherein said polym...
|
|
WO/2012/147470 |
[Problem] To provide a therapeutic agent which can promote the recruitment of PDGFRα-positive cells such as bone marrow-derived mesenchymal stem cells in blood and the accumulation of the PDGFRα-positive cells in damaged tissues, both ...
|
|
WO/2012/149491 |
The invention features compositions and methods for the increased production of mevalonate, isoprene, isoprenoid precursor molecules, and/or isoprenoids in microorganisms by engineering a microorganism for increased carbon flux towards m...
|
|
WO/2012/149484 |
Disclosed herein are methods and compositions for the cryopreservation of stem cells, such as stem-cell derived retinal pigment epithelial cells, that have been seeded onto and cultured on a substrate, such as a polymeric substrate. Such...
|
